Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes the recent study findings lead to the development of faster, better-acting sildenafil oral formulations. The animal study was conducted at a third-party independent laboratory located in the United States and involved 20 male Sprague-Dawley rats (two groups of 10 rats each) being treated with a single dose of the DehydraTECH-sildenafil and Control-sildenafil formulations.

To view the full press release, visit https://cnw.fm/RCwOn

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption with cannabinoids and nicotine by 5 to 10 times, and in some instances with cannabinoids by as much as 27 times; reduce time of onset from one to two hours to minutes; and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, antiviral drugs; nonsteroidal, anti-inflammatory drugs (“NSAIDs”); PDE5 inhibitors; and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious cannabinoid products for use on SARS-CoV-2 (COVID-19); FLGC plans to pursue the fastest path to market via a preventative immunomodulating product and to explore the possibility of use as a therapeutic. If the company’s request is approved, Flora’s formulation would be the first product containing cannabinoids to be approved for use against COVID-19 by the Colombian government. “We are honored to receive the advice and guidelines from INVIMA as we begin this exciting research process,” said Flora Growth president and CEO Luis Merchan in the press release. “The Flora Pharma division seeks to obtain evidence to support this product’s use against SARS-CoV-2 and bring to market an effective, cannabinoid-based product. . . . At Flora Growth, we believe in following the research, and there have been several promising studies published in just the last few months on the application of cannabinoids in certain treatments. We are excited for our Flora Pharma researchers to build upon this progress and generate new data for how cannabis could help consumers around the world, leveraging this natural, botanical alternative.”

To view the full press release, visit https://cnw.fm/YxXoh

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Thailand Greenlights Marijuana Home Grows

Earlier this week, the narcotics board in Thailand announced that it would be removing marijuana from its list of controlled drugs, which would allow households in the country to grow the herb. Thailand was the first country in southeast Asia to legalize cannabis for research and medical use in 2018.

Under this new law, individuals can grow marijuana at home after they have notified the local government. However, the country’s Health Minister Anutin Charnvirakul stated in an interview that the marijuana grown can’t be used for commercial purposes if one hadn’t obtained a license.

Before home growing of marijuana plants becomes legal in the country, citizens will have to wait for 120 days to pass after the rule has been published in the official Royal Gazette.

The country’s health ministry plans to also introduce a draft measure to parliament soon that includes guidelines on the legal use of marijuana, including the plant’s commercial use and production as well as details on its recreational use.

In a previous statement, the country’s food and drug regulator chief Paisal Dankhum stated that homegrown marijuana could only be utilized for medical purposes such as traditional medicine, noting that random inspections would be carried out. Under the draft measure, punishments for growing marijuana at home without notifying one’s local government will be a fine of about 20,000 baht, which is roughly $605. Individuals found selling cannabis without a license will be fined roughly $9,000 and/or be jailed for three years.

This move is the next step in the country’s goal of promoting marijuana as a cash crop and allowing farming families to grow the plant as a way to generate income. Data from the World Bank shows that nearly one-third of Thailand’s labor force is involved in agriculture.

Last year, Thai cosmetic companies and drink manufacturers launched products with CBD and hemp after the use of this compound was approved for use in consumer goods. CBD (cannabidiol) is one of the two main compounds found in marijuana, the other substance being THC. Unlike THC, which induces a high, CBD doesn’t make people high.

Before this recent measure was introduced, licensed cultivators of marijuana were only allowed to use the plant’s leaves, stalks, roots and stems. The partial ban on the other parts of the marijuana plant was approved during Thailand’s marijuana legalization process. It was implemented because the plant’s flowers, buds and seeds usually contain high amounts of THC.

As additional countries and jurisdictions bring cannabis prohibition to an end, more individuals will have access to marijuana-based offerings, such as BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) suite of health & wellness products.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Long Will Cannabis Edibles Remain in the Body?

Smoking cannabis flower is the most popular way to consume the popular drug. For decades, centuries even, it was the most common way of taking cannabis. However, there has been an increasing number of people, both regular users and newbies, who have been turning away from smoking to edibles in the past decade or two. This is partly because people are becoming more aware of the health risks attributed to smoking and are looking for healthier alternatives that will allow them to consume cannabis without endangering their health.

Edibles fill this niche quite nicely. In fact, cannabis-infused products have become so popular over the past couple of years that experts predict the global cannabis edibles market will be worth a whopping $11.8 billion by 2027. However, plenty of people don’t know much about cannabis-infused edibles and how they affect the body other than the fact that they are edible. This ignorance is often the difference between experiencing an enjoyable high or descending into an anxiety-ridden panic attack.

The main difference between eating edibles and smoking cannabis flower is that when you consume a cannabis edible, the cannabis stays in your system for much longer. When you smoke cannabis flower, the cannabinoids contained in the smoke are instantly absorbed into your blood by the vast network of blood vessels in your lungs. Edibles, on the other hand, have to go through a longer route before they reach your blood. As a result, a cannabis edible will remain in your body for much longer than cannabis flower, resulting in a more sustained high.

How does this work?

After you eat a cannabis-infused edible, its first stop will be the stomach. Here, digestive juices will break the edibles down and blood vessels along the stomach and digestive tract will absorb the THC within the edible. This THC, along with any other cannabinoids, will head to the liver where it is converted into 11-hyrdoxy THC before gradually entering general circulation over the next couple of hours. Since 11-hyrdoxy THC is more potent and psychoactive than regular THC, edibles tend to create an intense, long-lasting high.

How long will cannabis edibles remain in your body? The answer: it depends.

For most people, the effects take 30 minutes to two hours to kick in and can last for up to 12 hours, and you could still be feeling residual effects up to 24 hours later depending on the strain. Furthermore, it may take your body days to completely purge the cannabis. For regular uses, it can take up to 30 days for the cannabis to leave their systems.

Given that the effects of cannabis can vary from one individual to another, it is best to start with a low-potency product obtained from one of the many licensed companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) so that you are certain that you are consuming the best available products on the market.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” BevCanna Enterprises’ recent accolades come amid a period of ongoing growth momentum for the company, most aptly illustrated through its strong third-quarter earnings report. In addition, its commercial prospects have also gone from strength to strength as the company worked toward broadening its product portfolio.

To view the full article, visit https://cnw.fm/bLrqV

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with top U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — What Could the Future Hold for Functional Drinks?

Over the past couple of decades, there has been a major decline in drinking culture. Unlike their predecessors, younger generations simply aren’t drinking as much alcohol. The World Health Organization reports that the number of drinkers worldwide has decreased by 5% and by up to 10% in some European countries since 2000. Last year, alcohol consumption in America fell by 5%. As consumers have become more health conscious, especially during the coronavirus pandemic, they have been opting for healthier alternatives.

Functional or nonalcoholic beverages are becoming increasingly popular in the wake of this antialcohol movement. Although nonalcoholic drinks are a relatively new product, experts expect the industry to see major growth as people continue to seek alcohol alternatives. The functional beverage market is poised to grow at a compound annual growth rate (“CAGR”) of 7% and achieve a $173.23 billion valuation by 2025, Research and Markets predicts. For most people, alcoholic beverages are a social drug; nonalcoholic alternatives allow people to derive most of the same benefits without having to spend the next day hung over.

A lot of the alternatives on the market are also infused with minerals, dietary fibers, vitamins, adaptogens, probiotics and cannabinoids such as THC or CBD. Coca-Cola, for instance, has launched a caffeinated cola drink with B vitamins and guarana extracts and invested millions of dollars in Health-Ade Kombucha. Pepsi has also developed a noncarbonated, enhanced water beverage called Driftwell that contains L-theanine. According to the cofounder and CEO of marijuana beverage brand Wunder, the nonalcoholic beverage movement may have started a while ago, but the pandemic kicked it into overdrive.

Beverage producers have noticed the increased interest in nonalcoholic beverages and as a result, the market now has a variety of zero or low alcohol spirits, wines and beers. Kim Cox, the SVP of account development at NieslenIQ, says these new beverages are designed to meet consumers’ health and wellness concerns. This includes lower alcoholic content, lower calorie and sugar count and, in some cases, sustainable production practice.

Major innovation in the segment is coming from smaller companies rather than the large brands flooding the market with nonalcoholic offerings. Smaller brands now have a shot in the beverage space thanks to more accessible production methods, allowing them to get products to consumers at lower costs. The functional beverage space still has some growing to do, according to Bambucha Kombucha CEO Michael ZonFrilli. For instance, more food service operators and retailers need to start stocking nonalcoholic beverages, he says.

From the way customers are taking to functional drinks, early entrants in the space, including BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), are poised to grab significant chunk of the market share before other players rush into this space in the years to come.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Marijuana Legalization in Europe Doesn’t Increase Underage Usage

Marijuana is the most used illicit substance globally, with roughly 90 million individuals in Europe alone having used the drug once in their lifetime. Recently, scientists from the Karolinska Institute in Stockholm conducted a study to determine whether changes in marijuana laws led to an increase in the recreational use of the herb by young adults and adolescents.

They found no evidence to support the claim that the legalization of marijuana causes an increase in the use of marijuana in individuals aged 15 to 34. Critics of marijuana legalization often argue that allowing the legal and free access of the drug will make it more attractive to young adults and teenagers, which they believe will automatically result in increased usage.

The researchers’ objective was to address concerns around social harm that stem from marijuana legalization changes, especially since changes in cannabis legislation in Europe have been initiated in countries such as Czech Republic, Estonia, the United Kingdom, Italy, Malta, Spain, Netherlands, Germany and Belgium. Prior studies conducted on the impact of changes in marijuana laws on the prevalence of use have yielded inconclusive results.

The researchers, all from the Department of Global Public Health, conducted an analysis of data collected by the EMCDDA from 11 countries in Europe. The data contained rates of self-reported marijuana use in 15- to 34-year-olds in the period between 1994 and 2017, as well as information on the marijuana policy changes implemented by the countries included in the study. These changes were classified as less lenient or more lenient.

The researchers used a time-series linear model to evaluate the changes in nation-specific trends over the particular period, in relation to policy changes. They discovered that the use of marijuana was, on average, stable or rising weakly in countries that hadn’t changed their legislations. This increase was also observed in countries where laws were changed to the extremes.

By contrast, the average use of cannabis declined after changes in laws, regardless of whether the change was classified as more lenient or less lenient. It should be noted that the researchers took into account inconsistencies in drug legislations that different European nations enforced as well as the challenges in collecting the data.

In their report, the researchers explained that their discoveries aligned with prior research that didn’t find any clear link between marijuana policy and the use of the herb. In their conclusion, the team of researchers noted that their findings did not support any substantial impact of marijuana legislation on the prevalence of recreational marijuana use among young adults and youth in Europe.

As more studies clear the air about the unfounded fears that cannabis legalization will lead to an explosion of teen marijuana use, more jurisdictions around the world are likely to open up to this herb and companies such as Flora Growth Corp. (NASDAQ: FLGC) are likely to have a broader international market to satisfy.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Cannabis Cultivators Are Reducing Plastics Use in Their Operations

For quite a while, cannabis cultivators relied on plastic in their operations. Despite being colloquially known as “weed,” high-quality cannabis requires specific conditions during certain growth periods for maximum growth. In the past, hemp and cannabis cultivators, especially those that employed outdoor grows, have used plastics to fight weeds, pot plants, and construct trellises. Many of them are now turning away from plastics in favor of ecofriendly alternatives.

Plastics now permeate nearly every facet of the environment. A new report from the United Nations Food Agriculture Organization shows that microplastics aren’t just choking our oceans and seas, they are in the ground as well. In fact, the U.S. warns, the land used to grow food and other consumer products is polluted with more plastics than even the oceans. Some marijuana cultivators are guilty of contributing to this pollution, which not only damages the environment but also presents a significant risk to food security and human health.

So how are hemp and marijuana growers reducing their reliance on plastics? For starters, they are foregoing plastic pots and trellis netting to cultivate their crop in growing beds. While plastic pots can be reused and recycled, they eventually have to be replaced, says Julia Jacobson, CEO of Oakland-based cannabis producer Aster Farms. Growing beds are a much better option, she says, because they can be installed virtually anywhere and reduce the number of plastic pots growers use. Furthermore, they give plants much more room to spread out and grow.

Trellis netting, which is used to space plants for better airflow and flower growth, as well as to protect the plants against mold and bud rot, contributes to a lot of plastic waste. It is rarely reused, she says, and tends to be shaped in a way that can be particularly harmful to sea life if it ends up in the oceans. As such, Aster Farms uses a compostable alternative. Cannabis cultivators could also move away from the PVC (polyvinyl chloride) pipes and polyethylene drip tubes and emitters, and lay flat tubing that they use for in-field drip irrigation, says Brandon Rivers, the founder and president of SLO Hemp Co.

Employing drip irrigation systems with flood, ditch or center pivot irrigation would be a great way for cultivators to reduce their plastic use, Rivers says. According to the new UN report, banning certain products and plastic polymers and setting penalties for their use can also help reduce plastic use among marijuana cultivators. However, that doesn’t seem plausible with America’s current political climate.

Consumers may be the ones to lead change this time. By choosing to spend their hard-earned money on sustainably grown cannabis products, they will ultimately drive demand for ecofriendly products. And companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are rising to the challenge in order to boost the ecofriendly credentials of the cannabis value chain.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — State of the State Addresses Full of Praise for Marijuana Programs

Governors from different states in the country have been proclaiming their cannabis reform plans and accomplishments as part of their annual budget requests and State of the State speeches. The proposals and statements from state executives show how marijuana has grown more mainstream, as its being discussed in venues alongside infrastructure, education and taxes.

Below are some of the things governors said about cannabis in 2022.

South Dakota

Gov. Kristi Noem of South Dakota is focused on the proper implementation of the state’s medical marijuana program, which was recently launched. In an interview, Noem stated that she was focused on ensuring that the state had the most responsible, safe and well-run medical marijuana program in the country.

Virginia

Ralph Northam, the former governor of Virginia, discussed the criminal justice implications of Virginia’s move to legalize marijuana in 2021 during his final address earlier this month, thanking lawmakers who supported the reform. The state’s current governor, Gov. Glenn Youngkin, noted that before creating a market for commercial cannabis sales and production, some work needed to be done.

Rhode Island

Gov. Dan McKee included a measure to legalize cannabis as part of his annual budget plan this year, which makes it the second time he has done so. If approved, the measure mandates that automatic marijuana expungements occur in the state. This is in addition to allowing individuals aged 21 and above to possess and buy up to an ounce of marijuana and store up to five ounces of cannabis in their primary residencse.

The measure will also apply a weight-based excise tax on cannabis growing, a retail excise tax of 10% and sales tax upon marijuana transactions.

New York

Earlier this month, Gov. Kathy Hochul of New York announced plans to establish a $200 million public-private fund that will promote social equity in the state’s flourishing cannabis market. The governor highlighted the importance of creating opportunities for all individuals in the state, in particular, those from historically marginalized communities.

Projections show that the state’s cannabis market will generate billions in revenue, especially after marijuana business licenses are approved.

New Mexico

In her State of the State speech, Gov. Michelle Lujan Grisham of New Mexico discussed the economic potential of the cannabis industry under the legalization initiative she signed in 2021. The state plans to expand its economic footprint in communities and create thousands of employment opportunities as well as revenue to support local services in the state.

Given the multifaceted effects that the products of cannabis companies such as RYAH Group Inc. (CSE: RYAH) are triggering in people’s lives, it isn’t surprising that many state governors are touting the successes of this nascent industry.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Closing of Embark Acquisition

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an innovative health and wellness beverages and products company, has closed on its acquisition of Embark Health Inc., solventless cannabis extraction and delivery technology provider. According to the company, the acquisition will be a significant driver of growth for BevCanna, accelerating its already strong upward trajectory. Embark owns a unique range of brands across all three cannabis 2.0 categories, meaning that BevCanna will now be able to sell differentiated and complementary adult-use and wellness products. In addition, Embark brings a British-Columbia-based, state-of-the-art production facility with $17 million in tangible and intangible assets to the deal along with experiences management and operations personnel. BevCanna announced the acquisition in September of last year. “Completing the acquisition of Embark Health is a significant milestone in BevCanna’s strategic transformation into a diversified health and wellness company,” said BevCanna CEO and chief strategic officer John Campbell in the press release. “Embark’s solventless cannabis extraction and enhanced delivery technology will be a robust driver of growth for the Company, further diversifying our unique portfolio of brands and adding valuable intellectual property and four innovative adult-use cannabis brands to our range of offerings.”

To view the full press release, visit https://cnw.fm/Msgyx

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a high-capacity, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.